dapagliflozin

Generic: dapagliflozin

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name dapagliflozin
Generic Name dapagliflozin
Labeler a-s medication solutions
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

dapagliflozin propanediol 5 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-7056
Product ID 50090-7056_45a2ec6f-a7e4-42bf-8890-51332f8cfbde
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA202293
Listing Expiration 2026-12-31
Marketing Start 2024-01-03

Pharmacologic Class

Classes
sodium-glucose cotransporter 2 inhibitor [epc] sodium-glucose transporter 2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500907056
Hyphenated Format 50090-7056

Supplemental Identifiers

RxCUI
1488574
UNII
887K2391VH

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dapagliflozin (source: ndc)
Generic Name dapagliflozin (source: ndc)
Application Number NDA202293 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-7056-0)
source: ndc

Packages (1)

Ingredients (1)

dapagliflozin propanediol (5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "45a2ec6f-a7e4-42bf-8890-51332f8cfbde", "openfda": {"unii": ["887K2391VH"], "rxcui": ["1488574"], "spl_set_id": ["82cdd5ad-df2b-4bdd-a3a6-a059040100b4"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-7056-0)", "package_ndc": "50090-7056-0", "marketing_start_date": "20240116"}], "brand_name": "DAPAGLIFLOZIN", "product_id": "50090-7056_45a2ec6f-a7e4-42bf-8890-51332f8cfbde", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "50090-7056", "generic_name": "DAPAGLIFLOZIN", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DAPAGLIFLOZIN", "active_ingredients": [{"name": "DAPAGLIFLOZIN PROPANEDIOL", "strength": "5 mg/1"}], "application_number": "NDA202293", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20240103", "listing_expiration_date": "20261231"}